지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.1
- 수록면
- 314 - 323 (10page)
- DOI
- 10.4143/crt.2023.667
이용수
초록· 키워드
오류제보하기
Purpose We designed and evaluated the clinical performance of a plasma circulating tumor DNA (ctDNA) panel of 112 genes in various subtypes of lymphoma.Materials and Methods Targeted deep sequencing with an error-corrected algorithm was performed in ctDNA from plasma samples that were collected before treatment in 42 lymphoma patients. Blood buffy coat was utilized as a germline control. We evaluated the targeted gene panel using mutation detection concordance on the plasma samples with matched tissue samples analyzed the mutation profiles of the ctDNA.Results Next-generation sequencing analysis using matched tissue samples was available for 18 of the 42 patients. At least one mutation was detected in the majority of matched tissue biopsy samples (88.9%) and plasma samples (83.3%). A considerable number of mutations (40.4%) that were detected in the tissue samples were also found in the matched plasma samples. Majority of patients (21/42) were diffuse large B cell lymphoma patients. The overall detection rate of ctDNA in patients was 85.7% (36/42). The frequently mutated genes included <i>PIM1, TET2, BCL2, KMT2D, KLHL6, HIST1H1E</i>, and <i>IRF8</i>. A cutoff concentration (4,506 pg/mL) of ctDNA provided 88.9% sensitivity and 82.1% specificity to predict ctDNA mutation detection. The ctDNA concentration correlated with elevated lactate dehydrogenase level and the disease stage.Conclusion Our design panel can detect many actionable gene mutations, including those at low frequency. Therefore, liquid biopsy can be applied clinically in the evaluation of lymphoma patients, especially in aggressive lymphoma patients.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma
Cancer Research and Treatment
2022 .04
-
Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma
Cancer Research and Treatment
2024 .07
-
Circulating Tumor DNA–Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas
Cancer Research and Treatment
2023 .01
-
Clinical Circulating Tumor DNA Testing for Precision Oncology
Cancer Research and Treatment
2023 .04
-
혈중 순환 종양 DNA 분석 임상 적용 가이드라인 소개
Laboratory Medicine Online
2024 .07
-
Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Clinical and Molecular Hepatology
2024 .04
-
A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA: LiquidLung-O-Cohort 2
Cancer Research and Treatment
2019 .01
-
Clinical Practice Guideline for Blood-based Circulating Tumor DNA Assays
Annals of Laboratory Medicine
2024 .05
-
Implication of Pre- and Post-Radiotherapy ctDNA Dynamics in Patients with Residual Triple-Negative Breast Cancer at Surgery after Neoadjuvant Chemotherapy: Findings from a Prospective Observational Study
Cancer Research and Treatment
2024 .04
-
Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers
Cancer Research and Treatment
2023 .04
-
Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations
Cancer Research and Treatment
2020 .01
-
Targeted Liquid Biopsy Using Irradiation to Facilitate the Release of Cell-Free DNA from a Spatially Aimed Tumor Tissue
Cancer Research and Treatment
2022 .01
-
Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance
Investigative and Clinical Urology
2021 .01
-
Composite follicular lymphoma and classic Hodgkin lymphoma
Journal of Pathology and Translational Medicine
2022 .01
-
Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in NSCLC
Cancer Research and Treatment
2024 .07
-
Pediatric B-cell Lymphoma, Unclassifiable, With Intermediate Features Between Those of Diffuse Large B-cell Lymphoma and Burkitt Lymphoma: A Report of Two Cases
Annals of Laboratory Medicine
2015 .01
-
Relapse of Ocular Lymphoma following Primary Testicular Diffuse Large B-cell Lymphoma
Journal of Retina
2023 .05
-
Bone Marrow Flow Cytometry in Staging of Patients With B-cell Non-Hodgkin Lymphoma
Annals of Laboratory Medicine
2015 .01
-
Treatment of indolent lymphoma
Blood Research
2022 .04
-
Current status and future perspectives of liquid biopsy in non-small cell lung cancer
Journal of Pathology and Translational Medicine
2020 .01
최근 본 자료
댓글(0)
0